169 related articles for article (PubMed ID: 9748317)
1. Change in environment of the P1 side chain upon progression from the Michaelis complex to the covalent serpin-proteinase complex.
Futamura A; Stratikos E; Olson ST; Gettins PG
Biochemistry; 1998 Sep; 37(38):13110-9. PubMed ID: 9748317
[TBL] [Abstract][Full Text] [Related]
2. Insight into the mechanism of serpin-proteinase inhibition from 2D [1H-15N] NMR studies of the 69 kDa alpha 1-proteinase inhibitor Pittsburgh-trypsin covalent complex.
Peterson FC; Gettins PG
Biochemistry; 2001 May; 40(21):6284-92. PubMed ID: 11371190
[TBL] [Abstract][Full Text] [Related]
3. Resolution of Michaelis complex, acylation, and conformational change steps in the reactions of the serpin, plasminogen activator inhibitor-1, with tissue plasminogen activator and trypsin.
Olson ST; Swanson R; Day D; Verhamme I; Kvassman J; Shore JD
Biochemistry; 2001 Oct; 40(39):11742-56. PubMed ID: 11570875
[TBL] [Abstract][Full Text] [Related]
4. Thermodynamic criterion for the conformation of P1 residues of substrates and of inhibitors in complexes with serine proteinases.
Qasim MA; Lu SM; Ding J; Bateman KS; James MN; Anderson S; Song J; Markley JL; Ganz PJ; Saunders CW; Laskowski M
Biochemistry; 1999 Jun; 38(22):7142-50. PubMed ID: 10353824
[TBL] [Abstract][Full Text] [Related]
5. Properties of the His57-Asp102 dyad of rat trypsin D189S in the zymogen, activated enzyme, and alpha1-proteinase inhibitor complexed forms.
Kaslik G; Westler WM; Gráf L; Markley JL
Arch Biochem Biophys; 1999 Feb; 362(2):254-64. PubMed ID: 9989934
[TBL] [Abstract][Full Text] [Related]
6. Role of the catalytic serine in the interactions of serine proteinases with protein inhibitors of the serpin family. Contribution of a covalent interaction to the binding energy of serpin-proteinase complexes.
Olson ST; Bock PE; Kvassman J; Shore JD; Lawrence DA; Ginsburg D; Björk I
J Biol Chem; 1995 Dec; 270(50):30007-17. PubMed ID: 8530403
[TBL] [Abstract][Full Text] [Related]
7. Mapping the serpin-proteinase complex using single cysteine variants of alpha1-proteinase inhibitor Pittsburgh.
Stratikos E; Gettins PG
J Biol Chem; 1998 Jun; 273(25):15582-9. PubMed ID: 9624149
[TBL] [Abstract][Full Text] [Related]
8. Formation of a noncovalent serpin-proteinase complex involves no conformational change in the serpin. Use of 1H-15N HSQC NMR as a sensitive nonperturbing monitor of conformation.
Peterson FC; Gordon NC; Gettins PG
Biochemistry; 2000 Oct; 39(39):11884-92. PubMed ID: 11009600
[TBL] [Abstract][Full Text] [Related]
9. The pH dependence of serpin-proteinase complex dissociation reveals a mechanism of complex stabilization involving inactive and active conformational states of the proteinase which are perturbable by calcium.
Calugaru SV; Swanson R; Olson ST
J Biol Chem; 2001 Aug; 276(35):32446-55. PubMed ID: 11404362
[TBL] [Abstract][Full Text] [Related]
10. Formation of the covalent serpin-proteinase complex involves translocation of the proteinase by more than 70 A and full insertion of the reactive center loop into beta-sheet A.
Stratikos E; Gettins PG
Proc Natl Acad Sci U S A; 1999 Apr; 96(9):4808-13. PubMed ID: 10220375
[TBL] [Abstract][Full Text] [Related]
11. Specificity and reactive loop length requirements for crmA inhibition of serine proteases.
Tesch LD; Raghavendra MP; Bedsted-Faarvang T; Gettins PG; Olson ST
Protein Sci; 2005 Feb; 14(2):533-42. PubMed ID: 15632287
[TBL] [Abstract][Full Text] [Related]
12. Kinetic mechanism of protease inhibition by alpha1-antitrypsin.
Kang UB; Baek JH; Ryu SH; Kim J; Yu MH; Lee C
Biochem Biophys Res Commun; 2004 Oct; 323(2):409-15. PubMed ID: 15369767
[TBL] [Abstract][Full Text] [Related]
13. The inhibitory specificity of human proteinase inhibitor 8 is expanded through the use of multiple reactive site residues.
Dahlen JR; Foster DC; Kisiel W
Biochem Biophys Res Commun; 1998 Mar; 244(1):172-7. PubMed ID: 9514892
[TBL] [Abstract][Full Text] [Related]
14. Intrinsic fluorescence changes and rapid kinetics of proteinase deformation during serpin inhibition.
Tew DJ; Bottomley SP
FEBS Lett; 2001 Apr; 494(1-2):30-3. PubMed ID: 11297729
[TBL] [Abstract][Full Text] [Related]
15. Effects of serpin binding on the target proteinase: global stabilization, localized increased structural flexibility, and conserved hydrogen bonding at the active site.
Kaslik G; Kardos J; Szabó E; Szilágyi L; Závodszky P; Westler WM; Markley JL; Gráf L
Biochemistry; 1997 May; 36(18):5455-64. PubMed ID: 9154928
[TBL] [Abstract][Full Text] [Related]
16. The P6-P2 region of serpins is critical for proteinase inhibition and complex stability.
Chaillan-Huntington CE; Gettins PG; Huntington JA; Patston PA
Biochemistry; 1997 Aug; 36(31):9562-70. PubMed ID: 9236002
[TBL] [Abstract][Full Text] [Related]
17. Major proteinase movement upon stable serpin-proteinase complex formation.
Stratikos E; Gettins PG
Proc Natl Acad Sci U S A; 1997 Jan; 94(2):453-8. PubMed ID: 9012804
[TBL] [Abstract][Full Text] [Related]
18. Apparent formation of sodium dodecyl sulfate-stable complexes between serpins and 3,4-dichloroisocoumarin-inactivated proteinases is due to regeneration of active proteinase from the inactivated enzyme.
Olson ST; Swanson R; Patston PA; Björk I
J Biol Chem; 1997 May; 272(20):13338-42. PubMed ID: 9148956
[TBL] [Abstract][Full Text] [Related]
19. Conformational distributions of protease-serpin complexes: a partially translocated complex.
Liu L; Mushero N; Hedstrom L; Gershenson A
Biochemistry; 2006 Sep; 45(36):10865-72. PubMed ID: 16953572
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of heparin and glucose on structural conformation of human alpha1 antitrypsin: evidence for a heparin-induced cleaved form of the inhibitor.
Finotti P; de Laureto PP
Arch Biochem Biophys; 1997 Nov; 347(1):19-29. PubMed ID: 9344460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
